血管性血友病因子助力肝移植等待名单的MELD非依赖风险分层
本研究评估等待肝移植患者登记时血管性血友病因子抗原(vWF-Ag)对等待名单死亡的预测价值。结果显示3个月内死亡者vWF-Ag升高(P<0.001),vWF-Ag与MELD-Na预测能力相当且独立,vWF-Ag截断值413%的比值比高于MELD-Na 20分,联合vWF-Ag可改善3个月等待名单死亡预测(AUC 0.804)。
要点
- 登记时单次vWF-Ag可预测肝移植等待名单早期死亡。
- vWF-Ag 413%识别3个月内死亡风险,OR高于MELD-Na 20分。
- vWF-Ag联合MELD-Na改善3个月等待名单死亡预测。
核心结论
- 登记肝移植时单次测量vWF-Ag可预测等待名单早期死亡。
- vWF-Ag与MELD-Na联合可改善风险分层,可能有助于优化器官分配以降低等待名单死亡率。
研究设计与样本
- 研究评估等待肝移植患者登记时的vWF-Ag,记录临床特征、MELD-Na及等待名单死亡率。
- 采用受试者工作特征曲线和净重分类改善评估3个月等待名单生存预测。
主要发现
- 等待名单3个月内死亡的患者vWF-Ag水平升高(P < 0.001)。
- vWF-Ag与MELD-Na对3个月等待名单死亡的预测能力相当且独立(AUC:vWF-Ag = 0.739;MELD-Na = 0.764)。
- vWF-Ag截断值413%识别3个月内死亡风险的OR = 10.873(95%CI 3.160, 36.084),高于MELD-Na 20分的OR = 7.594(95%CI 2.578, 22.372),P < 0.001。
- 将vWF-Ag纳入MELD-Na方程显著改善3个月等待名单死亡预测(AUC:MELD-Na-vWF = 0.804)。
关键数值与推荐
- vWF-Ag截断值413%用于识别登记后3个月内死亡风险。
- MELD-Na截断值20分作为既往发表的参考阈值。
- 联合模型MELD-Na-vWF的AUC为0.804。
临床怎么用
- 考虑在肝移植登记时检测vWF-Ag,辅助MELD-Na进行等待名单风险分层。
- 对vWF-Ag≥413%的患者可加强监测或优先分配器官以降低早期死亡率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The Model for End-Stage Liver Disease (MELD) is used for clinical decision-making and organ allocation for orthotopic liver transplantation (OLT) and was previously upgraded through inclusion of serum sodium (Na) concentrations (MELD-Na). However, MELD-Na may underestimate complications arising from portal hypertension or infection. The von Willebrand factor (vWF) antigen (vWF-Ag) correlates with portal pressure and seems capable of predicting complications in patients with cirrhosis. Accordingly, this study aimed to evaluate vWF-Ag as an adjunct surrogate marker for risk stratification on the waiting list for OLT. APPROACH AND RESULTS: Hence, WF-Ag at time of listing was assessed in patients listed for OLT. Clinical characteristics, MELD-Na, and mortality on the waiting list were recorded. Prediction of 3-month waiting-list survival was assessed by receiver operating characteristics and net reclassification improvement. Interestingly, patients dying within 3 months on the waiting list displayed elevated levels of vWF-Ag (P < 0.001). MELD-Na and vWF-Ag were comparable and independent in their predictive potential for 3-month mortality on the waiting list (area under the curve [AUC], vWF-Ag = 0.739; MELD-Na = 0.764). Importantly, a vWF-Ag cutoff at 413% identified patients at risk for death within 3 months of listing with a higher odds ratio (OR) than the previously published cutoff at a MELD-Na of 20 points (vWF-Ag, OR = 10.873, 95% confidence interval [CI], 3.160, 36.084; MELD-Na, OR = 7.594, 95% CI, 2.578, 22.372; P < 0.001, respectively). Ultimately, inclusion of vWF-Ag into the MELD-Na equation significantly improved prediction of 3-month waiting-list mortality (AUC, MELD-Na-vWF = 0.804). CONCLUSIONS: A single measurement of vWF-Ag at listing for OLT predicts early mortality. Combining vWF-Ag levels with MELD-Na improves risk stratification and may help to prioritize organ allocation to decrease waiting-list mortality.
引用
- Györi GP, Pereyra D, Rumpf B, et al. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation. Hepatology. 2020. PMID: 31773739. doi:10.1002/hep.31047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。